UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Diversify Advisory Services LLC

Diversify Advisory Services LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,283 shares of the healthcare conglomerate’s stock after selling 2,132 shares during the period. Diversify Advisory Services LLC’s holdings in UnitedHealth Group were worth $3,272,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Pacer Advisors Inc. boosted its stake in UnitedHealth Group by 5.7% during the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after buying an additional 3,525 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its stake in shares of UnitedHealth Group by 3.4% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 700,864 shares of the healthcare conglomerate’s stock worth $356,922,000 after purchasing an additional 23,129 shares during the last quarter. ProShare Advisors LLC lifted its stake in UnitedHealth Group by 7.9% during the second quarter. ProShare Advisors LLC now owns 245,171 shares of the healthcare conglomerate’s stock valued at $124,856,000 after purchasing an additional 17,861 shares during the last quarter. Frank Rimerman Advisors LLC grew its position in UnitedHealth Group by 61,354.2% in the second quarter. Frank Rimerman Advisors LLC now owns 14,749 shares of the healthcare conglomerate’s stock worth $7,511,000 after buying an additional 14,725 shares during the last quarter. Finally, 1832 Asset Management L.P. lifted its position in shares of UnitedHealth Group by 12.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,797,607 shares of the healthcare conglomerate’s stock valued at $915,449,000 after acquiring an additional 192,128 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. TD Cowen lifted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Price Performance

NYSE UNH opened at $510.03 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $469.37 billion, a P/E ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The stock’s 50-day moving average is $549.37 and its two-hundred day moving average is $563.18. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.